Poly Medicure Ltd
NSE:POLYMED

Watchlist Manager
Poly Medicure Ltd Logo
Poly Medicure Ltd
NSE:POLYMED
Watchlist
Price: 2 715 INR 2.25% Market Closed
Market Cap: 275B INR
Have any thoughts about
Poly Medicure Ltd?
Write Note

Profitability Summary

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

High Profitability Stocks
Health Care Industry

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
Poly Medicure Ltd

Revenue
15.2B INR
Cost of Revenue
-5.1B INR
Gross Profit
10.1B INR
Operating Expenses
-6.8B INR
Operating Income
3.3B INR
Other Expenses
-382.6m INR
Net Income
2.9B INR

Margins Comparison
Poly Medicure Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
IN
Poly Medicure Ltd
NSE:POLYMED
275B INR
67%
22%
19%
JP
Hoya Corp
TSE:7741
7T JPY
86%
28%
24%
CH
Alcon AG
SIX:ALC
37.8B CHF
55%
13%
11%
DK
Coloplast A/S
CSE:COLO B
205.9B DKK
68%
27%
19%
US
Align Technology Inc
NASDAQ:ALGN
16B USD
70%
17%
11%
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
53.9B CNY
73%
46%
42%
CA
Bausch + Lomb Corp
NYSE:BLCO
7B USD
61%
4%
-8%
UK
ConvaTec Group PLC
LSE:CTEC
5.3B GBP
56%
13%
7%
CH
Ypsomed Holding AG
SIX:YPSN
5.2B CHF
34%
16%
14%
US
Merit Medical Systems Inc
NASDAQ:MMSI
5.9B USD
47%
12%
9%
KR
HLB Inc
KOSDAQ:028300
8T KRW
11%
-306%
-472%
Country IN
Market Cap 275B INR
Gross Margin
67%
Operating Margin
22%
Net Margin
19%
Country JP
Market Cap 7T JPY
Gross Margin
86%
Operating Margin
28%
Net Margin
24%
Country CH
Market Cap 37.8B CHF
Gross Margin
55%
Operating Margin
13%
Net Margin
11%
Country DK
Market Cap 205.9B DKK
Gross Margin
68%
Operating Margin
27%
Net Margin
19%
Country US
Market Cap 16B USD
Gross Margin
70%
Operating Margin
17%
Net Margin
11%
Country CN
Market Cap 53.9B CNY
Gross Margin
73%
Operating Margin
46%
Net Margin
42%
Country CA
Market Cap 7B USD
Gross Margin
61%
Operating Margin
4%
Net Margin
-8%
Country UK
Market Cap 5.3B GBP
Gross Margin
56%
Operating Margin
13%
Net Margin
7%
Country CH
Market Cap 5.2B CHF
Gross Margin
34%
Operating Margin
16%
Net Margin
14%
Country US
Market Cap 5.9B USD
Gross Margin
47%
Operating Margin
12%
Net Margin
9%
Country KR
Market Cap 8T KRW
Gross Margin
11%
Operating Margin
-306%
Net Margin
-472%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
Poly Medicure Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
IN
Poly Medicure Ltd
NSE:POLYMED
275B INR
15%
12%
17%
17%
JP
Hoya Corp
TSE:7741
7T JPY
20%
16%
22%
28%
CH
Alcon AG
SIX:ALC
37.8B CHF
5%
4%
5%
5%
DK
Coloplast A/S
CSE:COLO B
205.9B DKK
29%
11%
21%
13%
US
Align Technology Inc
NASDAQ:ALGN
16B USD
11%
7%
16%
9%
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
53.9B CNY
25%
23%
27%
38%
CA
Bausch + Lomb Corp
NYSE:BLCO
7B USD
-5%
-3%
2%
2%
UK
ConvaTec Group PLC
LSE:CTEC
5.3B GBP
9%
4%
9%
7%
CH
Ypsomed Holding AG
SIX:YPSN
5.2B CHF
13%
8%
14%
9%
US
Merit Medical Systems Inc
NASDAQ:MMSI
5.9B USD
9%
6%
8%
7%
KR
HLB Inc
KOSDAQ:028300
8T KRW
-38%
-25%
-19%
-19%
Country IN
Market Cap 275B INR
ROE
15%
ROA
12%
ROCE
17%
ROIC
17%
Country JP
Market Cap 7T JPY
ROE
20%
ROA
16%
ROCE
22%
ROIC
28%
Country CH
Market Cap 37.8B CHF
ROE
5%
ROA
4%
ROCE
5%
ROIC
5%
Country DK
Market Cap 205.9B DKK
ROE
29%
ROA
11%
ROCE
21%
ROIC
13%
Country US
Market Cap 16B USD
ROE
11%
ROA
7%
ROCE
16%
ROIC
9%
Country CN
Market Cap 53.9B CNY
ROE
25%
ROA
23%
ROCE
27%
ROIC
38%
Country CA
Market Cap 7B USD
ROE
-5%
ROA
-3%
ROCE
2%
ROIC
2%
Country UK
Market Cap 5.3B GBP
ROE
9%
ROA
4%
ROCE
9%
ROIC
7%
Country CH
Market Cap 5.2B CHF
ROE
13%
ROA
8%
ROCE
14%
ROIC
9%
Country US
Market Cap 5.9B USD
ROE
9%
ROA
6%
ROCE
8%
ROIC
7%
Country KR
Market Cap 8T KRW
ROE
-38%
ROA
-25%
ROCE
-19%
ROIC
-19%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More
Back to Top